These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 24064904

  • 1. An importance of identification of double variant methylenetetrahydrofolate reductase gene C677T and A1298C in cis configuration for pharmacogenetic studies.
    Palmirotta R, Leone B, De Marchis ML, Ludovici G, Savonarola A, Ferroni P, Rundek T, Roselli M, Della-Morte D, Guadagni F.
    Blood Coagul Fibrinolysis; 2013 Oct; 24(7):784-6. PubMed ID: 24064904
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia.
    Lopez-Lopez E, Martin-Guerrero I, Ballesteros J, Garcia-Orad A.
    Pharmacogenomics J; 2013 Dec; 13(6):498-506. PubMed ID: 23089671
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients.
    Chiusolo P, Reddiconto G, Farina G, Mannocci A, Fiorini A, Palladino M, La Torre G, Fianchi L, Sorà F, Laurenti L, Leone G, Sica S.
    Leuk Res; 2007 Dec; 31(12):1669-74. PubMed ID: 17512587
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.
    Aplenc R, Thompson J, Han P, La M, Zhao H, Lange B, Rebbeck T.
    Cancer Res; 2005 Mar 15; 65(6):2482-7. PubMed ID: 15781665
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of the methylenetetrahydrofolate reductase 677 and 1298 polymorphisms in Cretan children with acute lymphoblastic leukemia.
    Karathanasis NV, Stiakaki E, Goulielmos GN, Kalmanti M.
    Genet Test Mol Biomarkers; 2011 Mar 15; 15(1-2):5-10. PubMed ID: 21117954
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of the relationship between methylenetetrahydrofolate reductase polymorphism and acute lymphoblastic leukemia: Evidence from an updated meta-analysis.
    Frikha R.
    J Oncol Pharm Pract; 2020 Oct 15; 26(7):1598-1610. PubMed ID: 32070201
    [Abstract] [Full Text] [Related]

  • 17. Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia.
    Pakakasama S, Kanchanakamhaeng K, Kajanachumpol S, Udomsubpayakul U, Sirachainan N, Thithapandha A, Hongeng S.
    Ann Hematol; 2007 Aug 15; 86(8):609-11. PubMed ID: 17323057
    [No Abstract] [Full Text] [Related]

  • 18. Methotrexate pharmacogenetics in Uruguayan adults with hematological malignant diseases.
    Giletti A, Vital M, Lorenzo M, Cardozo P, Borelli G, Gabus R, Martínez L, Díaz L, Assar R, Rodriguez MN, Esperón P.
    Eur J Pharm Sci; 2017 Nov 15; 109():480-485. PubMed ID: 28887233
    [Abstract] [Full Text] [Related]

  • 19. Methylenetetrahydrofolate reductase A1298C genotypes are associated with the risks of acute lymphoblastic leukaemia and chronic myelogenous leukaemia in the Korean population.
    Hur M, Park JY, Cho HC, Lee KM, Shin HY, Cho HI.
    Clin Lab Haematol; 2006 Jun 15; 28(3):154-9. PubMed ID: 16706930
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.